News MeiraGTx plans to take Parkinson's gene therapy into phase 3 Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial.
R&D Life sciences in Ireland: Nurturing talent, innovating excel... Late last month, pharmaphorum was invited on an IDA Ireland-organised press tour of the life sciences industry in Ireland’s West, permitting an inside peek into the world-class life science
News UK modernises gene therapy definition in regulatory revamp The UK is planning changes to the definition of gene therapies and other genetic medicines, moving to a mechanism-based approach aligned with the EU.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.